Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties

Bioorg Med Chem. 2015 Aug 1;23(15):4181-4187. doi: 10.1016/j.bmc.2015.06.050. Epub 2015 Jun 26.

Abstract

A series of new Schiff bases derived from sulfanilamide, 3-fluorosulfanilamide or 4-(2-aminoethyl)-benzenesulfonamide containing either a hydrophobic or a hydrophilic tail, have been investigated as inhibitors of three β-carbonic anhydrases (CA, EC 4.2.1.1) from three different microorganisms. Their antifungal, antibacterial and antiprotozoan activities have been determined against the pathogenic fungus Cryptococcus neoformans, the bacterial pathogen Brucella suis and the protozoan parasite Leishmania donovani chagasi, responsible for Leishmaniasis. The results of these inhibition studies show that all three enzymes were efficiently inhibited by the Schiff base sulfonamides with KI values in the nanomolar or submicromolar range, depending on the nature of the tail, coming from the aryl/heteroaryl moiety present in the starting aldehyde employed in the synthesis. Furthermore, the compounds hereby investigated revealed high β-CAs selectivity over the ubiquitous, physiologically relevant and off-target human isoforms (CA I and II) and to be more potent as antifungal and antibacterial than as antiprotozoan potential drugs.

Keywords: Anti-infective; Bacteria; Beta-carbonic anhydrase; Fungi; Pathogenic microorganism; Protozoa; Schiff base; Selective inhibitor; Sulfonamide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Antifungal Agents / chemistry
  • Antifungal Agents / pharmacology*
  • Antiprotozoal Agents / chemistry
  • Antiprotozoal Agents / pharmacology*
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / metabolism
  • Brucella suis / drug effects
  • Carbonic Anhydrase I / metabolism
  • Carbonic Anhydrase II / metabolism
  • Carbonic Anhydrase Inhibitors / chemistry*
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrases / metabolism
  • Cryptococcus neoformans / drug effects
  • Drug Evaluation, Preclinical / methods
  • Fungal Proteins / antagonists & inhibitors
  • Fungal Proteins / metabolism
  • Humans
  • Leishmania infantum / drug effects
  • Protozoan Proteins / antagonists & inhibitors
  • Protozoan Proteins / metabolism
  • Schiff Bases
  • Sulfanilamide
  • Sulfanilamides / chemistry

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antiprotozoal Agents
  • Bacterial Proteins
  • Carbonic Anhydrase Inhibitors
  • Fungal Proteins
  • Protozoan Proteins
  • Schiff Bases
  • Sulfanilamides
  • Sulfanilamide
  • Carbonic Anhydrase I
  • Carbonic Anhydrase II
  • Carbonic Anhydrases